Search This Blog

De Omnibus Dubitandum - Lux Veritas

Showing posts with label Lawsuits. Show all posts
Showing posts with label Lawsuits. Show all posts

Monday, December 14, 2020

Viewpoint: Glyphosate-cancer trials illustrate how tort lawyers undermine science in the courtroom

| December 14, 2020

Should we be fair to chemical manufacturers when they are sued? First of all, who are they? Since everything in the universe is made of up of chemicals, isn’t every manufacturer a chemical manufacturer. OK, no, it is only chemical manufacturers that make chemicals. Some are useful but hazardous, meaning they require special treatment. There are large ones like Bayer, but two-thirds of the 13,500 chemical plants are small.

If they are successfully sued, who actually loses? First, employees. The plant may have to reduce production or close down, which means employees get laid off. Lawsuits will affect the owners of the company’s stock some of whom are retirees on a pension.

We should pay attention because these types of lawsuits are growing. Perhaps because regulation moves so slowly, tort lawyers have found profitable opportunities by linking any chemical exposure to consumer or worker harm. The most widely known suit has been against Bayer, the owners of Roundup, that faced tens of thousands of claims claiming exposure to the herbicide caused non-Hodgkin’s lymphoma. Currently, the company has agreed to pay $10 billion to settle the claims.

Unlike federal agencies like the EPA, FDA, USDA and Department of Labor, law is applied unevenly “across different jurisdictions, different judges, and different jury pools.” The variation in how the law is applied to chemicals is so wide that there is even a website for “Judicial Hellholes.” If you’ve ever seen an ad asking if you or a loved one has been exposed to a chemical and you think it caused your ailment, it’s most likely from trial lawyers who spend millions on advertising to recruit potential plaintiffs and influence juries..........To Read More....

 

Wednesday, September 5, 2018

Roundup on trial: Everything you need to know about the glyphosate herbicide controversy

| | September 5, 2018

A California jury awarded two hundred and eighty nine million dollars …. to a former groundskeeper for a California school district who claims that he contracted non-Hodgkins lymphoma from exposure to a commercial preparation of glyphosate …. The jury decision elicited extensive commentaries from experts and non-experts, both pro and con ….

First of all, let’s point out that this trial dealt with occupational exposure to glyphosate and had nothing to do with trace amounts of the chemical in our food supply. Nevertheless, the Environmental Working Group (EWG) …. took the opportunity to …. publish a report about traces of glyphosate in oat products and suggested that these were a threat to health.

The highest concentration EWG found was 760 parts per billion. That would mean that a small child eating 100 grams of the cereal would consume 0.076 milligrams of glyphosate ….The 0.076 mg consumed is 1/66th of this …. By comparison, Health Canada has set a maximum residue level of glyphosate in oats at 15,000 parts per billion!

[S]cience is on the side of glyphosate’s benefits outweighing its risks, but emotion is on the side of the plaintiff. And we have often seen that emotion trumps science. Furthermore, the defendant in this lawsuit, Monsanto, was essentially challenged to prove that Mr. Johnson’s lymphoma was not caused by glyphosate. That is an impossible task.........To Read More.....

Sunday, August 26, 2018

Science and Environmental Litigation

By Chuck Dinerstein — August 21, 2018 @ American Council on Science and Health

The judiciary frequently acts in its role as a counterbalance to executive and legislative action and non-action. A new article in Nature Climate Change finds patterns of climate change litigation identified in the Sabin Center for Climate Change database, a part of Columbia’s School of Law. As it turns out, there are some instructive patterns, and we begin to see the role of Science – with a capital S.
The Who and Why of Litigation

Who files these cases? - Environmental non-government organizations were the largest plaintiff, initiating 42% of cases, industry followed at 30%, with city, state and federal government involved in about 11%.  The Sabin database contained 838 cases from 1990 to 2016.
  • 46% dealt with atmospheric environmental issues especially coal-fired power plants
  • 8.5% dealt with energy efficiency or renewables
  • 4% addressed water quality
  • 8% raised concerns about biodiversity
The courts were asked to address the reduction in greenhouse gases, to assess responsibility for environmental impacts and as a way to change both corporate behavior and public debate (the latter presumably through policy).

For those interested in keeping some form of score, in those cases involving atmospheric environmental issues, the courts more often sided with the “anti-regulators.” On the other hand, “pro-regulatory” litigants won more often when the cases involved issues of energy. And whether it was an NGO or an industrial group acting as plaintiff, they were generally less successful than the defendants. The authors felt that this might reflect both weaker cases and the courts more often deferring to the judgment of state officials.

The Who and the Where

To file a court case, the plaintiff must have “standing,” a legal term that establishes that the plaintiff has suffered some injury [1] or that there is a causal relationship between the defendant’s actions and those injuries. In establishing standing, NGOs often found that collaborating with local stakeholders was helpful. If the NGO could not demonstrate “their” injury, then an alliance with a local community group who had suffered injury got them a seat at the plaintiff’s table. These collaborations were not limited to the NGOs; industrial litigants found that joining forces with other large business within the sector with also in their interest. The authors suggest that these collaborations helped to demonstrate a larger group of concerned citizens, helped to mask disagreements among the stakeholders and in some cases gain otherwise unavailable legitimacy.

The where of litigation is referred to as venue - the jurisdiction in which the case is heard. The plaintiff’s goal is to identify the most favorable court for hearing their case. Delaware is home to many corporations because its corporate laws frequently favor their concerns, which has resulted to more corporate litigation in that state which in turn creates a large body of case law to serve as precedence. California is a more favored venue when statutory concerns are pivotal, because of their strict environmental rulings and the case laws that have flowed from those decision. And in both instances, prior case law often provides a sense of how the courts may act.

The role of science

Unsurprisingly, both NGOs and industry felt that scientific evidence was an essential factor in the court’s ruling. Equally unsurprising was that the litigants offered differing evidence and used it in differing ways. The “pro-regulatory” litigants, the NGOs, used their scientific evidence to establish a causal link between the defendants and the injury. This could serve two purposes, first to warrant their standing before the court and then to substantiate the environmental effects causing the injury.  The “anti-regulatory” litigants also found the same two uses; using the “dismal science” of economics to demonstrate their economic injury, and the environmental science to refute the claims of the plaintiffs.

The researchers did not review the court transcripts, so what science and how it was presented remains unknown, but from studying the Court’s written judgments they found that scientific evidence was cited in roughly half the cases; it made no difference whether it was for or against regulation.

So what can we conclude? Everyone brings their own “scientific evidence” to the table; that their evidence differs is not a flaw in the scientific method, it is a feature. Scientific theory and evidence represent are a best current approximation, and there is always an unknown element. So our evidence will differ, only time and further replication will push us towards the “right” answer. As the authors write:

“The results turn on factors such as the roles courts think are appropriate for the judiciary in influencing important environmental, social and economic policy questions, how they react to scientific evidence that relates to climate change presented before agencies or during civil trials and what remedies they are willing to impose.”

The question we need to ask is whether a courtroom is the best venue for that discussion. The courts act on these matters because the other branches of the government are unable or unwilling to have this discussion; I think that those other branches are as able as the courts so that just leaves unwilling.

[1] Injury does not have to be physical, it can be emotional or anything that reflects a form of damage.

Source: Strategies in and outcomes of climate change litigation in the United States Nature Climate Change DOI: 10.1038/s41558-018-0240-8

Thursday, August 16, 2018

Putting Science on the Stand

By Richard Zuber August 16, 2018

In a closely watched decision, a California jury ruled last week that Monsanto owed former Bay Area school groundskeeper Dewayne Johnson $289 million in damages. Though Monsanto maintains that its products are safe, pointing to clean bills of health from a wide array of national health agencies, Johnson's attorneys argued that the company covered up the risks of the weed-killers Roundup and Ranger Pro – which they say were responsible for their client's terminal cancer.

The lawsuit thus carefully avoided delving into the complex epidemiology of Roundup's active ingredient, glyphosate, arguing instead that the groundskeeper's illness arose from glyphosate's interactions with the weed-killer's other ingredients. Yet with even less available evidence about the safety of Roundup's formulation than about glyphosate, the verdict has revealed far more about the challenges of evaluating science in the courtroom than about the herbicide's alleged risks.............. Read more

Saturday, April 21, 2018

Trial Lawyers Still Don't Have a Winning Case Against Monsanto

Apr 21, 2018 Brian McNicoll

Trial lawyers hoping to take a big bite out of food producer Monsanto’s bottom line with a lawsuit over its most popular weed-killer have run into a problem – the judge who they need to convince their arguments are valid is not buying it.  In 2015, the International Agency for Research and Cancer, based in Lyon, France, declared glyphosate, the main ingredient in Roundup, the world’s most popular weed-killer, a “probably human carcinogen.”

No other scientific body has reached that conclusion. Indeed, the Environmental Protection Agency says glyphosate is safe for humans when used in accordance with label directions, the National Institute of Health has concluded it is not a carcinogen and, as a Monsanto official pointed out, more than 800 scientific, medical, peer-reviewed articles have been published saying there is no association whatsoever between glyphosate and any form of cancer........To Read More.....